Regulatory and Informational Gaps in the Over-the-Counter Eye Care Product Industry-Over the Counter, Under the Radar

David N Younessi; John C Lin; Timothy M Janetos

doi:10.1001/jamaophthalmol.2023.4961

Regulatory and Informational Gaps in the Over-the-Counter Eye Care Product Industry-Over the Counter, Under the Radar

JAMA Ophthalmol. 2023 Dec 1;141(12):1105-1106. doi: 10.1001/jamaophthalmol.2023.4961.

Authors

David N Younessi¹, John C Lin², Timothy M Janetos¹

Affiliations

¹ Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 37917092
DOI: 10.1001/jamaophthalmol.2023.4961

No abstract available

Plain language summary

This Viewpoint describes the limitations of regulatory oversight for over-the-counter eye care products and challenges in providing clinical recommendations.

MeSH terms

Humans
Nonprescription Drugs* / standards
Ophthalmic Solutions* / standards

Substances

Nonprescription Drugs
Ophthalmic Solutions